|
Wednesday, February 8, 2012
Managed Care
Coventry Health Care's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Wednesday, February 8, 2012; Source: Seeking Alpha
Coventry Health Care Q4 2011 Earnings Call February 8, 2012 8:30 AM ET
Room For Compromise on Contraception Coverage?
Wednesday, February 8, 2012, 8:45 am ET; Source: The Wall Street Journal
The Obama administration is looking for possible compromises on a policy that requires most religious employers to offer health plans that cover the cost of contraception for their workers, the WSJ reports, citing people familiar with the discussions.
Pharmacy Benefit Management
CVS Caremark 4Q Profit Rises, 2012 Outlook Climbs
Wednesday, February 8, 2012; Source: Seeking Alpha
Drugstore chain Walgreen's loss of a big client is turning into rival CVS Caremark's gain so far this year.
AstraZeneca US Broadens Income Eligibility for Prescription Savings Programs
Wednesday, February 8, 2012, 9:00 am ET; Source: Business Wire
AstraZeneca announced today that it broadened the income eligibility for its AZ&Me Prescription Savings programs to enable more people to qualify for free medicines.
Pharmaceutical and Bio Tech
Apotex Pays Bristol, Sanofi Damages Over Plavix
Wednesday, February 8, 2012, 10:40 am ET; Source: Associated Press
A major generic drugmaker has paid Bristol-Myers Squibb Co. and Sanofi SA more than $442 million to end a decade-long patent infringement case over blockbuster blood thinner Plavix, the world's second-best-selling drug.
The Government Is Dragging Its Feet on New Vaccines
Tuesday, February 7, 2012, 4:41 pm ET; Source: Forbes.com
One of the most important questions plaguing President Obama’s Patient Protection and Affordable Care Act is whether it would politicize, or ration, access to health care.
Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ORTHO TRI-CYCLEN(R) LO
Wednesday, February 8, 2012, 8:30 am ET; Source: PR Newswire
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has reached a settlement with Janssen Pharmaceuticals, Inc. (formerly Ortho-McNeil-Janssen Pharmaceuticals, Inc.) on outstanding patent litigation related to Watson's generic version of Janssen's ORTHO TRI-CYCLEN LO (norgestimate/ethinyl estradiol) tablets.
Forest Laboratories, Gedeon Richter Announce Positive Phase III Results for Antipsychotic Agent
Wednesday, February 8, 2012, 2:00 am ET; Source: Business Wire
Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from a Phase III clinical trial of cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with bipolar I disorder.
Healthcare Technology
Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
Wednesday, February 8, 2012, 8:30 am ET; Source: PR Newswire
Boston Scientific Corporation announces the U.S. launch of the TruePath CTO Device, designed to facilitate the crossing of chronic total occlusions (CTOs, or complete blockages) within the peripheral vasculature.
Medtronic Stent Resulted in 90% Freedom From Reinterventions in Narrowed Leg Arteries At 12 Months in International Study
Wednesday, February 8, 2012, 8:00 am ET; Source: Business Wire
Consistent with its commitment to developing better treatments for peripheral arterial disease (PAD), Medtronic Inc. today announced the one-year results of an international study of the Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis in the superficial femoral artery (SFA).
Medtronic Stent Resulted in 90% Freedom From Reinterventions in Narrowed Leg Arteries At 12 Months in International Study
Wednesday, February 8, 2012, 8:00 am ET; Source: Business Wire
Consistent with its commitment to developing better treatments for peripheral arterial disease (PAD), Medtronic Inc. today announced the one-year results of an international study of the Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis in the superficial femoral artery (SFA).
Investing In Diversified Nanotechnology With Harris & Harris Group
Wednesday, February 8, 2012, 7:19 am ET; Source: Seeking Alpha
There is a growing trend which supports the idea that nanotechnology is now in a phase of widespread adoption throughout technology platforms used for commercial use.
Omnicare Announces First Electronic Prescribing Solution For Controlled Substances In Institutional Settings
Wednesday, February 8, 2012, 8:03 am ET; Source: Reuters
Omnicare, Inc. today announced the pilot launch of a new application for its cutting edge OmniviewDr platform.
|
